262 - Progress, Not Perfection: Managing Substance Use Disorders and STI Syndemics in HIV Clinic

Saturday, October 19, 2024

3:15 PM – 4:30 PM US PT

Location: 515 A

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

NA

Nicholas Allen, DNP (he/him/his)

Infectious Disease ARNP
Washington State Department of Corrections
Seattle, WA, United States
Lydia Barakat, MD (she/her/hers)

Associate Professor
Infectious DIsease
Yale School of Medicine
New Haven, Connecticut, United States
Colleen Kelley, MD, MPH (she/her/hers)

Associate Professor of Medicine
Emory University
Decatur, GA, United States

Faculty(s)

Hermione Hurley, MBCHB (she/her/hers)

Physician
Denver Health
Denver, CO, United States
Jennifer Fulcher, MD, PhD (she/her/hers)

Associate Professor
David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California
Los Angeles, CA, United States
Shobita Rajagopalan, MD. MS. MPH (she/her/hers)

Associate Medical Director/STD Controller
Los Angeles County Dept. of Public Health
Division of HIV and STD Programs
Los Angeles, CA, United States

Disclosure(s):

Nicholas Allen, DNP: No financial relationships to disclose

Lydia A. Barakat, MD: No financial relationships to disclose

Colleen F. Kelley, MD, MPH: Gilead Sciences: Grant/Research Support (Ongoing); Humanigen, Inc: Grant/Research Support (Terminated); Moderna, Inc.: Grant/Research Support (Terminated); Novavax, Inc.: Grant/Research Support (Terminated); ViiV Healtcare: Grant/Research Support (Ongoing)

Hermione Hurley, MBCHB: No financial relationships to disclose

Jennifer A. Fulcher, MD, PhD: No financial relationships to disclose

Shobita Rajagopalan, MD. MS. MPH: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe strategies for treatment for opioid use disorder in an hiv clinic;
analyze clinical considerations for people with hiv who use stimulants;
recommend offering integrated care for sexually transmitted infections, viral hepatitis, and substance use disorders in an hiv clinic.

Presentations:

3:15 PM – 3:40 PM US PT

Management of Substance Use Disorders in HIV clinic
Speaker: Hermione Hurley, MBCHB (she/her/hers) – Denver Health
3:40 PM – 4:05 PM US PT

Stimulants and HIV
Speaker: Jennifer A. Fulcher, MD, PhD (she/her/hers) – David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Diseases, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California
4:05 PM – 4:30 PM US PT

Meeting People Where They Are: Field Based Testing and Treatment for STIs in Los Angeles County
Speaker: Shobita Rajagopalan, MD. MS. MPH (she/her/hers) – Division of HIV and STD Programs